Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women

被引:78
作者
Kim, So-Youn [1 ]
Kim, Seul Ki [2 ,3 ]
Lee, Jung Ryeot [2 ,3 ]
Woodruff, Teresa K. [1 ]
机构
[1] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Lurie Bldg 10-250,303 East Super St, Chicago, IL 60611 USA
[2] Seoul Natl Univ, Dept Obstet & Gynecol, Bundang Hosp, Songnam, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea
基金
美国国家卫生研究院;
关键词
Cancer; Chemo- or radiation therapy; Fertility Preservation; Technologies; Precision Medicine; Oocyte; CRYOPRESERVED OVARIAN TISSUE; ENCAPSULATED 3-DIMENSIONAL CULTURE; VITRO MATURED OOCYTES; BREAST-CANCER; EMBRYO DEVELOPMENT; LIVE BIRTH; PREANTRAL FOLLICLES; FOLLICULAR LOSS; GERM-CELLS; 1ST STEP;
D O I
10.3802/jgo.2016.27.e22
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
As the number of young cancer survivors increases, quality of life after cancer treatment is becoming an ever more important consideration. According to a report from the American Cancer Society, approximately 810,170 women were diagnosed with cancer in 2015 in the United States. Among female cancer survivors, 1 in 250 are of reproductive age. Anticancer therapies can result in infertility or sterility and can have long-term negative effects on bone health, cardiovascular health as a result of reproductive endocrine function. Fertility preservation has been identified by many young patients diagnosed with cancer as second only to survival in terms of importance. The development of fertility preservation technologies aims to help patients diagnosed with cancer to preserve or protect their fertility prior to exposure to chemo- or radiation therapy, thus improving their chances of having a family and enhancing their quality of life as a cancer survivor. Currently, sperm, egg, and embryo banking are standard of care for preserving fertility for reproductive-age cancer patients; ovarian tissue cryopreservation is still considered experimental. Adoption and surrogate may also need to be considered. All patients should receive information about the fertility risks associated with their cancer treatment and the fertility preservation options available in a timely manner, whether or not they decide to ultimately pursue fertility preservation. Because of the ever expanding number of options for treating cancer and preserving fertility, there is now an opportunity to take a precision medicine approach to informing patients about the fertility risks associated with their cancer treatment and the fertility preservation options that are available to them.
引用
收藏
页数:18
相关论文
共 118 条
[71]   Primary Ovarian Insufficiency [J].
Nelson, Lawrence M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (06) :606-614
[72]   Embryo development after heterotopic transplantation of cryopreserved ovarian tissue [J].
Oktay, K ;
Buyuk, E ;
Veeck, L ;
Zaninovic, N ;
Xu, KP ;
Takeuchi, T ;
Opsahl, M ;
Rosenwaks, Z .
LANCET, 2004, 363 (9412) :837-840
[73]   In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation [J].
Oktay, K. ;
Buyuk, E. ;
Rodriguez-Wallberg, K. A. ;
Sahin, G. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2010, 20 (05) :634-638
[74]   Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy [J].
Oktay, Kutluk ;
Hourvitz, Ariel ;
Sahin, Gulnaz ;
Oktem, Ozgur ;
Safro, Bradley ;
Cil, Aylin ;
Bang, Heejung .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (10) :3885-3890
[75]   Novel approach for the three-dimensional culture of granulosa cell-oocyte complexes [J].
Pangas, SA ;
Saudye, H ;
Shea, LD ;
Woodruff, TK .
TISSUE ENGINEERING, 2003, 9 (05) :1013-1021
[76]   Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction [J].
Perez, GI ;
Knudson, CM ;
Leykin, L ;
Korsmeyer, SJ ;
Tilly, JL .
NATURE MEDICINE, 1997, 3 (11) :1228-1232
[77]   First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient [J].
Prasath, E. B. ;
Chan, M. L. H. ;
Wong, W. H. W. ;
Lim, C. J. W. ;
Tharmalingam, M. D. ;
Hendricks, M. ;
Loh, S. F. ;
Chia, Y. N. .
HUMAN REPRODUCTION, 2014, 29 (02) :276-278
[78]   Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study [J].
Rienzi, Laura ;
Romano, Stefania ;
Albricci, Laura ;
Maggiulli, Roberta ;
Capalbo, Antonio ;
Baroni, Elena ;
Colamaria, Silvia ;
Sapienza, Fabio ;
Ubaldi, Filippo .
HUMAN REPRODUCTION, 2010, 25 (01) :66-73
[79]   Biochemical pregnancy after fertilization of an oocyte aspirated from a heterotopic autotransplant of cryopreserved ovarian tissue: Case report [J].
Rosendahl, M. ;
Loft, A. ;
Byskov, A. G. ;
Ziebe, S. ;
Schmidt, K. T. L. ;
Andersen, A. Nyboe ;
Ottosen, C. ;
Andersen, C. Yding .
HUMAN REPRODUCTION, 2006, 21 (08) :2006-2009
[80]   The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature [J].
Rosendahl, Mikkel ;
Greve, Tine ;
Andersen, Claus Yding .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2013, 30 (01) :11-24